ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,809Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 2035

$874K Total Retail Price of All Prescriptions

Rank: 73 out of 2035

424 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 424 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 17,112 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 933 905 1 4
LISINOPRIL 833 800 2 3
SIMVASTATIN 670 655 3 1
FUROSEMIDE 661 630 4 7
METOPROLOL TARTRATE 563 544 5 8
HYDROCODONE-ACETAMINOPHEN 508 476 S3 6 2
WARFARIN SODIUM 482 481 7 11
AMLODIPINE BESYLATE 437 432 8 6
DONEPEZIL HCL 394 394 9 24
POTASSIUM CHLORIDE 332 323 10 18
GABAPENTIN 308 298 11 14
NAMENDA 275 275 12 37
MIRTAZAPINE 268 268 13 46
DIVALPROEX SODIUM 254 240 14 75
TRAZODONE HCL 253 239 15 50
QUETIAPINE FUMARATE 248 248 16 70
TRAMADOL HCL 247 246 17 19
SERTRALINE HCL 225 225 18 23
CITALOPRAM HBR 223 202 19 20
RISPERIDONE 192 174 20 68
CLOPIDOGREL 189 187 21 30
METFORMIN HCL 187 180 22 9
OMEPRAZOLE 184 169 23 5
LANTUS SOLOSTAR 180 166 24 66
FENTANYL 163 161 S2 25 53
CARBIDOPA-LEVODOPA 161 149 26 94
METOPROLOL SUCCINATE 159 157 27 16
ALBUTEROL SULFATE 159 153 27 90
PRAVASTATIN SODIUM 158 156 29 17
LEVETIRACETAM 153 143 30 87
HYDRALAZINE HCL 141 122 31 45
GLIPIZIDE 138 138 32 54
PLAVIX 137 127 33 49
SPIRIVA 131 131 34 44
LANTUS 126 125 35 40
ISOSORBIDE MONONITRATE ER 123 117 36 32
ATENOLOL 121 120 37 10
CARVEDILOL 116 111 38 22
CYMBALTA 101 100 39 59
NOVOLOG 98 97 40 95
SEROQUEL 97 94 41 153
PAROXETINE HCL 93 93 42 69
TAMSULOSIN HCL 89 86 43 25
NYSTATIN 89 89 43 103
HUMALOG 86 83 45 139
HYDROCHLOROTHIAZIDE 85 82 46 12
SPIRONOLACTONE 84 73 47 65
RANITIDINE HCL 83 78 48 28
ACETAMINOPHEN-CODEINE 83 68 S3 48 52
LEVOFLOXACIN 83 77 48 99
TRAVATAN Z 81 76 51 199
SANTYL 80 80 52 192
CEPHALEXIN 79 77 53 91
ALENDRONATE SODIUM 79 77 53 27
LIDODERM 77 70 55 72
LOSARTAN POTASSIUM 74 69 56 15
ADVAIR DISKUS 73 72 57 38
OXYCONTIN 73 73 S2 57 152
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 66 59 110
PANTOPRAZOLE SODIUM 71 55 60 42
LACTULOSE 71 50 60 96
BRIMONIDINE TARTRATE 69 69 62 239
OXYBUTYNIN CHLORIDE 68 67 63 102
PREDNISONE 67 61 64 36
VOLTAREN 67 67 64 141
OLANZAPINE 65 65 66 121
ESCITALOPRAM OXALATE 64 63 67 77
CHLORTHALIDONE 61 60 68 145
VALPROIC ACID 59 58 69 235
TERAZOSIN HCL 56 51 70 149
ZOLPIDEM TARTRATE 55 51 71 21
LATANOPROST 54 54 72 177
ATORVASTATIN CALCIUM 54 50 72 13
BUPROPION HCL SR 53 53 74 202
OXYCODONE HCL 53 52 S2 74 62
PHENYTOIN SODIUM EXTENDED 52 51 76 132
NOVOLOG FLEXPEN 52 51 76 133
CIPROFLOXACIN HCL 51 49 78 63
FAMOTIDINE 51 51 78 71
BACLOFEN 50 50 80 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.